Palladium Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
BCM
GIM
Palladium Partners's ABMD Position: Q1 2022 in Review
Palladium Partners held its Abiomed Inc (ABMD) position steady in Q1 2022 at 1,478 shares worth $490K. The position accounts for 0.02% of the portfolio, ranked #245.
Palladium Partners first reported a position in ABMD in Q3 2016 and has held it in 20 quarters since. The position peaked at $630K in Q1 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.
- Palladium Partners held 1,478 shares of Abiomed Inc worth $490K as of Q1 2022.
- Palladium Partners left its Abiomed Inc share count unchanged in Q1 2022.
- Abiomed Inc made up 0.02% of Palladium Partners's portfolio in Q1 2022, its #245 holding.
- Palladium Partners first reported a position in Abiomed Inc in Q3 2016 and has held it in 20 quarters since.
- Palladium Partners's Abiomed Inc position peaked at $630K in Q1 2018.
- 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.